Matthew J. Dowd and Professor Adam Mossoff Pen Article Concerning Genus Claims and Fearmongering

Matthew J. Dowd and Professor Adam Mossoff address the new enablement rule to be debated before the U.S. Supreme Court in Amgen v. Sanofi. This rule ignores decades of genus-claim use that has incentivized inventors to create groundbreaking technology like the lightbulb and life-saving medical drugs. Genus claims are in danger due to fearmongering amici briefs that are authored by misinformed activists and policy organizations. This article emphasizes the historical importance of genus claims across all industries, from high-tech to medical. The article can be found here https://today.westlaw.com/Document/Ibd2751d9b85311ed8636e1a02dc72ff6/View/FullText.html?transitionType=CategoryPageItem&contextData=(sc.Default)&firstPage=true&bhcp=1